Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study

Introduction Children with septo-optic-pituitary dysplasia (SOD) may experience a range of visual impairments and hormonal dysfunctions beyond developmental delay/intellectual disability. The literature describes sleep fragmentation, circadian rhythm disruptions and reduced sleep efficiency. These m...

Full description

Saved in:
Bibliographic Details
Main Authors: Romina Romaniello, Sabrina Signorini, Elena Ballante, Valentina Franco, Valentina De Giorgis, Ludovica Pasca, Guido Catalano, Federica Morelli, Carlo Alberto Quaranta, Helene Vitali, Francesca Dattrino, Francesca Crema, Paola Rota, Costanza Varesio
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/1/e090675.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524962753511424
author Romina Romaniello
Sabrina Signorini
Elena Ballante
Valentina Franco
Valentina De Giorgis
Ludovica Pasca
Guido Catalano
Federica Morelli
Carlo Alberto Quaranta
Helene Vitali
Francesca Dattrino
Francesca Crema
Paola Rota
Costanza Varesio
author_facet Romina Romaniello
Sabrina Signorini
Elena Ballante
Valentina Franco
Valentina De Giorgis
Ludovica Pasca
Guido Catalano
Federica Morelli
Carlo Alberto Quaranta
Helene Vitali
Francesca Dattrino
Francesca Crema
Paola Rota
Costanza Varesio
author_sort Romina Romaniello
collection DOAJ
description Introduction Children with septo-optic-pituitary dysplasia (SOD) may experience a range of visual impairments and hormonal dysfunctions beyond developmental delay/intellectual disability. The literature describes sleep fragmentation, circadian rhythm disruptions and reduced sleep efficiency. These manifestations are believed to be closely linked to both structural and functional abnormalities associated with SOD, potentially disrupting the natural circadian rhythm. Both anomalies in midline brain structures and decreased visual input could potentially impact melatonin secretion, although a distinct melatonin profile for SOD patients has yet to be identified. Furthermore, the specific contribution of these factors to sleep disturbances in SOD remains unexplored. The aim of this study is to evaluate the quality of sleep and its characteristics, along with the melatonin profile, among paediatric patients diagnosed with SOD. A comparison will be made between these findings and those of children with isolated bilateral visual impairment, as well as patients with agenesis of the corpus callosum.Methods and analysis Participants aged between 3 and 18 years previously diagnosed with SOD will be recruited prospectively. Each participant will be assessed at baseline and at each follow-up visit scheduled to evaluate the clinical course. Sleep quality and daytime sleepiness changes will be tracked using actigraphic assessment, standardised sleep questionnaires and a sleep EEG. Additionally, plasma and salivary melatonin profiles will be assessed for each participant.Ethics and dissemination This study has been approved by local Ethics Committee (N°0049187/23). The study findings will be shared through publication in an international peer-reviewed journal and presented at both national and international conferences.Trial registration number NCT06262152.
format Article
id doaj-art-3a0ffdc2d12f42bc95ff89ac84783e68
institution Kabale University
issn 2044-6055
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-3a0ffdc2d12f42bc95ff89ac84783e682025-01-17T20:40:10ZengBMJ Publishing GroupBMJ Open2044-60552025-01-0115110.1136/bmjopen-2024-090675Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort studyRomina Romaniello0Sabrina Signorini1Elena Ballante2Valentina Franco3Valentina De Giorgis4Ludovica Pasca5Guido Catalano6Federica Morelli7Carlo Alberto Quaranta8Helene Vitali9Francesca Dattrino10Francesca Crema11Paola Rota12Costanza Varesio131 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy2 Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy1 IRCCS Mondino Foundation, Pavia, Italy4 Unit for Visually Impaired People, Istituto Italiano di Tecnologia, Genoa, Italy1 IRCCS Mondino Foundation, Pavia, Italy7 Clinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy8 Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milano, Italy1 IRCCS Mondino Foundation, Pavia, ItalyIntroduction Children with septo-optic-pituitary dysplasia (SOD) may experience a range of visual impairments and hormonal dysfunctions beyond developmental delay/intellectual disability. The literature describes sleep fragmentation, circadian rhythm disruptions and reduced sleep efficiency. These manifestations are believed to be closely linked to both structural and functional abnormalities associated with SOD, potentially disrupting the natural circadian rhythm. Both anomalies in midline brain structures and decreased visual input could potentially impact melatonin secretion, although a distinct melatonin profile for SOD patients has yet to be identified. Furthermore, the specific contribution of these factors to sleep disturbances in SOD remains unexplored. The aim of this study is to evaluate the quality of sleep and its characteristics, along with the melatonin profile, among paediatric patients diagnosed with SOD. A comparison will be made between these findings and those of children with isolated bilateral visual impairment, as well as patients with agenesis of the corpus callosum.Methods and analysis Participants aged between 3 and 18 years previously diagnosed with SOD will be recruited prospectively. Each participant will be assessed at baseline and at each follow-up visit scheduled to evaluate the clinical course. Sleep quality and daytime sleepiness changes will be tracked using actigraphic assessment, standardised sleep questionnaires and a sleep EEG. Additionally, plasma and salivary melatonin profiles will be assessed for each participant.Ethics and dissemination This study has been approved by local Ethics Committee (N°0049187/23). The study findings will be shared through publication in an international peer-reviewed journal and presented at both national and international conferences.Trial registration number NCT06262152.https://bmjopen.bmj.com/content/15/1/e090675.full
spellingShingle Romina Romaniello
Sabrina Signorini
Elena Ballante
Valentina Franco
Valentina De Giorgis
Ludovica Pasca
Guido Catalano
Federica Morelli
Carlo Alberto Quaranta
Helene Vitali
Francesca Dattrino
Francesca Crema
Paola Rota
Costanza Varesio
Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
BMJ Open
title Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
title_full Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
title_fullStr Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
title_full_unstemmed Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
title_short Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study
title_sort sleep profile in patients with septo optic pituitary dysplasia protocol for a prospective cohort study
url https://bmjopen.bmj.com/content/15/1/e090675.full
work_keys_str_mv AT rominaromaniello sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT sabrinasignorini sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT elenaballante sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT valentinafranco sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT valentinadegiorgis sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT ludovicapasca sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT guidocatalano sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT federicamorelli sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT carloalbertoquaranta sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT helenevitali sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT francescadattrino sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT francescacrema sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT paolarota sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy
AT costanzavaresio sleepprofileinpatientswithseptoopticpituitarydysplasiaprotocolforaprospectivecohortstudy